Outcome of Regular Inhaled Treatment in GOLD A Chronic Obstructive Pulmonary Disease Patients

Background: The 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends regular bronchodilator therapy in all group A patients with chronic obstructive pulmonary disease (COPD). Objective: The aim of this study was to evaluate whether regular inhaled treatment in group A patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiration 2019-10, Vol.98 (4), p.312-320
Hauptverfasser:	Cho, Jaeyoung, Lee, Chang-Hoon, Hwang, Yong-Il, Lee, Jin Hwa, Kim, Tae-Hyung, Lee, Ji-Hyun, Oh, Yeon-Mok, Yoo, Kwang Ha, Jung, Ki-Suck, Lee, Sang-Do
Format:	Artikel
Sprache:	eng
Schlagworte:	Bronchodilator agents Clinical Investigations Drug therapy Inhaled medication Lung diseases, Obstructive Patient outcomes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background: The 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends regular bronchodilator therapy in all group A patients with chronic obstructive pulmonary disease (COPD). Objective: The aim of this study was to evaluate whether regular inhaled treatment in group A patients with COPD improves their health outcomes, including exacerbations and symptoms. Methods: We recruited patients from 2 Korean prospective cohorts. Eligible COPD patients had a modified Medical Research Council (mMRC) dyspnea score of
ISSN:	0025-7931 1423-0356
DOI:	10.1159/000495756